Insulin therapy in type 2 diabetic patients: effects on arterial blood pressure and endothelin-1 plasma levels.
To evaluate the possible effect of short- and long-term insulin treatment on arterial blood pressure (BP) and endothelin-1 (ET-1) plasma levels in type 2 diabetic patients. Seven type 2 diabetic patients with secondary failure to oral hypoglycemic drugs (SFOH) were studied. Twenty-four-hour arterial BP monitorization (Spacelabs 90207) was performed before initiation of insulin treatment (time 0), 6 days after (time 1) and 1 year later (time 2). Moreover, ET-1 plasma levels were measured. Insulin treatment did not produce any variation in systolic (124.3 +/- 11.6; 120.7 +/- 7.9; 127.0 +/- 13.4 mmHg) and diastolic (72.8 +/- 5.9; 71.5 +/- 3.4; 71.8 +/- 5.2 mmHg) 24-h BP monitorization at times 0, 1 and 2, respectively. The systolic and diastolic day/night differences did not change in the three times studied. Neither were significant differences observed in ET-1 plasma levels. In patients with SFOH, insulin treatment did not induce any short- or long-term increase in BP or any variation in plasma ET-1 levels.